Skye Bioscience Shares Are Trading Higher After the Company Announced the Debut of Its "Anatomy of Progress" Nimacimab Development Update Video Series and Availability of Presentations Related to the Development of Its Anti-obesity Drug, Nimacimab.
Skye Bioscience的股票价格在公司宣布推出其 "进展解剖学 "的Nimacimab开发更新视频系列及与其抗肥胖药物Nimacimab开发相关的演示可用后上涨。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
